About Xeris Pharmaceuticals
Xeris Pharmaceuticals (NASDAQ:XERS) is engaged in developing and commercializing innovative therapies in endocrinology and neurology. The company focuses on creating products that use its proprietary formulation technology platforms, including XeriSol™ and XeriJect™, which are designed to enhance the efficacy, safety, and convenience of therapies for patients with serious and chronic medical conditions. Xeris Pharmaceuticals aims to address significant unmet medical needs by bringing to market treatments that offer better clinical outcomes and more accessible patient care. Its portfolio includes Gvoke® for severe hypoglycemia in diabetes patients, reflecting the company's commitment to improving the lives of those living with challenging medical conditions. Through ongoing research and development, Xeris seeks to expand its product offerings and deliver innovative healthcare solutions worldwide.
Snapshot
Operations
Products and/or services of Xeris Pharmaceuticals
- Gvoke HypoPen and PFS, a ready-to-use, room-temperature stable liquid glucagon for severe hypoglycemia.
- Recorlev (levoketoconazole), a cortisol synthesis inhibitor for endogenous Cushing’s syndrome treatment.
- Keveyis (dichlorphenamide), the first FDA-approved drug for primary hyperkalemic and hypokalemic periodic paralysis.
- XeriJect technology, focusing on formulation technology for injectable and infusible drug candidates.
- Self-administered glucagon for exercise-induced hypoglycemia, offering a convenient option for individuals with diabetes.
- A pipeline of developmental programs targeting endocrine disorders, leveraging novel delivery technologies for better patient care.
Xeris Pharmaceuticals executive team
- Mr. John P. ShannonCEO & Director
- Mr. Kevin McCullochPresident & COO
- Mr. Steven M. PieperChief Financial Officer
- Ms. Beth P. Hecht J.D.Chief Legal Officer & Corporate Secretary
- Ms. Allison WeySenior Vice President of Investor Relations & Corporate Communications
- Mr. Brian ConnerSVP of Quality and Chief Compliance & Risk Officer
- Ms. Kendal KorteSenior Vice President of Human Resources
- Dr. Anh Nguyen M.B.A., M.D.Chief Medical Officer